Adlai Nortye Ltd (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ANL Nasdaq 8731 http://www.adlainortye.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adlai Nortye Ltd (ADR)

Adlai Nortye Ltd.'s (NASDAQ:ANL) largest shareholders are retail investors with 59% ownership, insiders own 16% - Mar 29th, 2024 12:40 pm
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development - Mar 29th, 2024 10:00 am
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC - Nov 17th, 2023 12:30 pm
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award - Oct 23rd, 2023 12:12 pm
Adlai Nortye Ltd. Announces Closing of Initial Public Offering - Oct 3rd, 2023 4:05 pm
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering - Sep 29th, 2023 6:46 am